Residency · Stanford, CA
Sponsored by Stanford Health Care
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Billy Loo
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Billy Loo
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
Cell · 2024 · 464 citations · Maximilian Diehn
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Billy Loo
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Billy Loo
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 571 citations · Steven Hancock
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.
Annals of oncology : official journal of the European Society for Medical Oncology · 2022 · 612 citations · Maximilian Diehn
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
The Journal of urology · 2022 · 411 citations · William Wong